Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
Optimizing Cimzia in Crohn's Patients

The purpose of this study is to determine if increasing the dose and/or dosing frequency of certolizumab pegol (Cimzia) is effective in regaining and optimizing response in patients with

cimzia
certolizumab pegol
  • 60 views
  • 08 Nov, 2020
  • 1 location
Pediatric Arthritis Study of Certolizumab Pegol

A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course

  • 30 views
  • 16 Sep, 2021
  • 46 locations
A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)

The purpose of the study is to assess systemic certolizumab pegol (CZP) exposure, the formation of anti-CZP antibodies and safety of CZP across the course of pregnancy in study participants with

interferon gamma
interferon gamma release assay
tuberculosis
certolizumab pegol
cimzia
  • 56 views
  • 22 Aug, 2021
  • 10 locations
A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

The purpose of the study is to evaluate the pharmacokinetics and safety of certolizumab pegol in adults with active rheumatoid arthritis.

certolizumab pegol
  • 0 views
  • 03 Jul, 2021
  • 15 locations
A Study to Evaluate the Efficacy Safety and Drug Concentration of Certolizumab Pegol (CZP) in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis (PSO)

The purpose of the study is to demonstrate the efficacy and safety of certolizumab pegol in the treatment of moderate to severe chronic plaque psoriasis in study participants aged 6 to 11 and 12

  • 9 views
  • 12 Sep, 2021
  • 50 locations
Assessing Patient Confidence in Biologic Medications

cycle. Examples of biologic medications commonly used in dermatology include tumor necrosis factor-alpha (TNF-alpha), blockers/inhibitors (etanercept, infliximab, certolizumab pegol, golimumab

tumor necrosis factor
ustekinumab
infliximab
tumor necrosis factor alpha
ixekizumab
  • 67 views
  • 09 Sep, 2021
  • 1 location
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

The purpose of the study is to assess the effectiveness of certolizumab pegol in patients with moderate to severe plaque psoriasis as part of routine clinical practice.

certolizumab pegol
  • 99 views
  • 28 Aug, 2021
  • 122 locations